Inhoudsopgave:
|
\u003cp\u003eDevelopments of antifungal agents have declined as compared to other antibiotics that have displayed a potent development with time. There is an urgent need for both prophylactic and therapeutic treatments worldwide to control the severity of infections caused by Candida. \u003ci\u003eAnticandidal Therapeutics\u003c/i\u003e provides the readers with a compiled knowledge of the fungal human infection Candida and the development of anticandidal drugs. \u003ci\u003eAnticandidal Therapeutics\u003c/i\u003e helps researchers form the basis for the discovery and development of novel anticandidal therapies. In 14 chapters this book provides collective information on anticandidal agents and their discovery and development with respect to major drug transporter families, different stages of anticandidal agent development, recent trends and progress in antifungal translational research, clinical studies status of anticandidal therapeutic agents, and drug repurposing for development of novel anticandidal agents.\u003c/p\u003e\u003cul\u003e \u003cli\u003e \u003cp\u003e⢠Highlights the mechanistic actions of some therapeutic agents against Candida. \u003c/p\u003e \u003cp\u003e⢠Focuses on anticandidal agents rather than general antifungal agents.\u003c/p\u003e \u003cp\u003e⢠Discusses the stage of development of new antifungal drugs, the repositioning of drugs, and how this could help in treatment. \u003c/p\u003e\u003c/li\u003e\u003c/ul\u003e |
nl
en